UNICA IRIS Institutional Research Information System

KOWALIK, MARTA ANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 94.499
NA - Nord America 3.841
AS - Asia 1.886
SA - Sud America 246
AF - Africa 77
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 100.554
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 93.391
US - Stati Uniti d'America 3.764
SG - Singapore 724
CN - Cina 573
SE - Svezia 275
VN - Vietnam 213
BR - Brasile 187
DE - Germania 184
UA - Ucraina 147
GB - Regno Unito 121
FI - Finlandia 117
FR - Francia 84
HK - Hong Kong 58
CA - Canada 55
IN - India 41
TR - Turchia 41
KR - Corea 37
ZA - Sudafrica 31
BD - Bangladesh 30
PL - Polonia 26
IQ - Iraq 24
NL - Olanda 23
AR - Argentina 21
BE - Belgio 20
JP - Giappone 19
MA - Marocco 19
RU - Federazione Russa 19
IR - Iran 18
MX - Messico 16
ES - Italia 15
PK - Pakistan 15
AT - Austria 14
JO - Giordania 11
EC - Ecuador 10
IE - Irlanda 10
MY - Malesia 9
CO - Colombia 8
LT - Lituania 8
CH - Svizzera 7
ID - Indonesia 7
PH - Filippine 7
UZ - Uzbekistan 7
VE - Venezuela 7
IL - Israele 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
DK - Danimarca 5
EG - Egitto 5
MT - Malta 5
TN - Tunisia 5
TW - Taiwan 5
AZ - Azerbaigian 4
CL - Cile 4
DZ - Algeria 4
HU - Ungheria 4
KE - Kenya 4
KZ - Kazakistan 4
PA - Panama 4
PE - Perù 4
PT - Portogallo 4
AU - Australia 3
CZ - Repubblica Ceca 3
LK - Sri Lanka 3
NG - Nigeria 3
PS - Palestinian Territory 3
PY - Paraguay 3
AL - Albania 2
AM - Armenia 2
BY - Bielorussia 2
ET - Etiopia 2
GR - Grecia 2
JM - Giamaica 2
KH - Cambogia 2
MU - Mauritius 2
NO - Norvegia 2
OM - Oman 2
RO - Romania 2
TH - Thailandia 2
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CG - Congo 1
EE - Estonia 1
EU - Europa 1
GE - Georgia 1
GH - Ghana 1
IM - Isola di Man 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
TM - Turkmenistan 1
UY - Uruguay 1
Totale 100.554
Salva come PNG Salva come JPEG
Città #
Cagliari 91.516
Uta 1.594
Singapore 452
Ashburn 440
Fairfield 328
San Jose 251
Woodbridge 216
Chandler 202
Nyköping 180
Houston 161
Ann Arbor 150
Boardman 145
Los Angeles 145
Beijing 127
Seattle 121
Wilmington 115
Dallas 114
Cambridge 106
Dearborn 82
Helsinki 79
Jacksonville 65
The Dalles 64
Santa Clara 61
Hong Kong 56
New York 56
Council Bluffs 51
Hanoi 49
Ho Chi Minh City 48
Lauterbourg 44
Shanghai 43
Hefei 42
Nanjing 31
Seoul 31
Frankfurt am Main 29
Dong Ket 28
London 28
Munich 25
Redwood City 23
Warsaw 23
Boston 22
Buffalo 21
Rome 21
Brussels 20
São Paulo 20
Toronto 20
Kocaeli 19
Milan 19
San Mateo 19
Guangzhou 18
Johannesburg 18
Montreal 18
Chicago 17
San Diego 17
Stockholm 17
Redondo Beach 16
Chennai 15
Denver 15
Atlanta 13
Casablanca 13
Pisa 13
Da Nang 12
Falls Church 12
Haiphong 12
Nuremberg 12
Phoenix 12
Turku 12
Amsterdam 11
Jiaxing 11
Mountain View 11
Orem 11
Amman 10
Brooklyn 10
Nanchang 10
Tokyo 10
Bari 9
Changsha 9
Dublin 9
Vienna 9
Baghdad 8
Manchester 8
Rio de Janeiro 8
Shenyang 8
Shenzhen 8
Tianjin 8
Augusta 7
Biên Hòa 7
Bogazici 7
Columbus 7
Dhaka 7
Düsseldorf 7
Florence 7
Leawood 7
Norwalk 7
Poplar 7
Pune 7
Auburn Hills 6
Ferrara 6
Lappeenranta 6
Milwaukee 6
Orange 6
Totale 98.039
Salva come PNG Salva come JPEG
Nome #
Thyroid hormone receptor ligands induce regression of rat preneoplastic liver lesions causing their reversion to a differentiated phenotype 6.013
Expression of c-jun is not mandatory for mouse hepatocyte proliferation induced by two nuclear receptor ligands: TCPOBOP and T3 4.971
Statistical health monitoring applied to a metabolomic study of experimental hepatocarcinogenesis: an alternative approach to supervised methods for the identification of false positives 4.261
Yes-associated protein regulation of adaptive liver enlargement and hepatocellular carcinoma development in mice 4.235
YAP activation is an early event and a potential therapeutic target in liver cancer development 4.043
Thyroid hormone (T3) and TRbeta agonist GC-1 inhibit/reverse nonalcoholic fatty liver in rats 3.958
Local hypothyroidism favors the progression of preneoplastic lesions to hepatocellular carcinoma in rats 3.875
TRbeta is the critical thyroid hormone receptor isoform in T3-induced proliferation of hepatocytes and pancreatic acinar cells 3.751
Cytokeratin-19 positivity is acquired along cancer progression and does not predict cell origin in rat hepatocarcinogenesis 3.708
Nrf2, but not β-catenin, mutation represents an early event in rat hepatocarcinogenesis 3.653
Emerging role of the pentose phosphate pathway in hepatocellular carcinoma 3.587
Global gene expression profile of normal and regenerating liver in young and old mice 3.565
Transcription profiling by array of mouse liver from TCPOBOP treated wild type and c-jun conditional knockout animals. 3.469
Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis 3.181
MicroRNA/gene profiling unveils early molecular changes and nuclear factor erythroid related factor 2 (NRF2) activation in a rat model recapitulating human hepatocellular carcinoma (HCC). 3.165
Induction of autophagy promotes the growth of early preneoplastic rat liver nodules 3.091
Reply to: "YAP in tumorigenesis: Friend or foe?" 2.767
High frequency of β-catenin mutations in mouse hepatocellular carcinomas induced by a nongenotoxic constitutive androstane receptor agonist 2.651
Reply to: Clinical correlation of miR-375 and alpha-fetoprotein in hepatocellular carcinoma: comparison in mice and humans 2.357
Accelerated entry into S phase and increased hepatocyte proliferation in c-jun conditional knock-out mice following administration of the CAR agonist TCPOBOP 2.344
Thyroid hormones, thyromimetics and their metabolites in the treatment of liver disease 2.329
Gender-specific interplay of signaling through β-catenin and CAR in the regulation of xenobiotic-induced hepatocyte proliferation 2.124
Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience 2.017
Animal models: A useful tool to unveil metabolic changes in hepatocellular carcinoma 1.666
Early metabolic changes in a liver carcinogenesis model 1.496
Design, synthesis and biological evaluation of novel TRβ selective agonists sustained by ADME-toxicity analysis 1.456
Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection 1.442
Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming 1.216
Early Metabolic Changes in preneoplastc nodules of the liver 1.174
Tg68, a novel thyroid hormone receptor‐β agonist for the treatment of NAFLD 963
Potential role of two novel agonists of thyroid hormone receptor-β on liver regeneration 961
Nrf2 Mutation/Activation Is Dispensable for the Development of Chemically Induced Mouse HCC 893
The density of hepatic autonomic innervation differs between compensatory and direct hyperplasia rat models 867
The double-sided of human leukocyte antigen-G molecules in type 1 autoimmune hepatitis 850
Effect of the ligands of thyroid hormone receptor on non-alcoholic fatty liver disease 837
Distinct Mechanisms Are Responsible for Nrf2-Keap1 Pathway Activation at Different Stages of Rat Hepatocarcinogenesis 836
Novel thyroid hormone receptor-beta agonist TG68 safely induces hepatic fat reduction in a non-alcoholic steatohepatitis rat model 745
mRNA-miRNA networks identify metabolic pathways associated to the anti-tumorigenic effect of thyroid hormone on preneoplastic nodules and hepatocellular carcinoma 694
Delta-globin gene expression improves sickle cell disease in a humanised mouse model 671
Novel thyroid hormone receptor-beta agonist TG68 safely induces hepatic fat reduction in a non-alcoholic steatohepatitis rat model 606
Diverse MicroRNAs-mRNA networks regulate the priming phase of mouse liver regeneration and of direct hyperplasia 516
Multi-Organ Morphological Findings in a Humanized Murine Model of Sickle Cell Trait 512
Sex difference in liver diseases: How preclinical models help to dissect the sex-related mechanisms sustaining NAFLD and hepatocellular carcinoma 457
THYROID HORMONE INHIBITS HEPATOCELLULAR CARCINOMA (HCC) DEVELOPMENT BY INTERFERING WITH THE METABOLIC PROFILE OF CANCER CELLS 456
Novel thyroid hormone receptor beta agonist TG68 safely induces hepatic fat loss reduction in a NASH mouse model 426
Characterization Of Early Stage Metabolic Perturbations In A Rat Model Of Hepatocellular Carcinogenesis 426
Novel thyroid hormone receptor-beta agonist TG68 safely induces hepatic fat reduction in a non-alcoholic steatohepatitis rat model 421
Potential use of TG68 - A novel thyromimetic - for the treatment of non-alcoholic fatty liver (NAFLD)-associated hepatocarcinogenesis 367
Metabolic reprogramming in Nrf2-driven proliferation of normal rat hepatocytes 322
Galectin-3 inhibition ameliorates hepatic steatosis in a multilineage 3D spheroid model 142
Estrogen-dependent activation of TRX2 reverses oxidative stress and metabolic dysfunction associated with steatotic disease 131
Lead induces cell-autonomous proliferation and metabolic reprogramming of hepatocytes 78
The role of OSM/OSMRβ axis in shaping the tumor microenvironment favoring MASLD-related HCC immune evasion 6
Totale 100.748
Salva come PNG Salva come JPEG
Categoria #
all - tutte 121.348
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 121.348
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.937 0 0 0 0 0 0 0 0 0 1.157 1.171 609
2021/20225.325 767 352 233 343 519 371 210 192 545 575 609 609
2022/20237.951 462 877 1.022 712 636 885 514 464 527 651 792 409
2023/20247.638 475 253 275 387 737 1.172 1.336 688 354 446 638 877
2024/202521.115 7.396 7.556 1.492 1.484 689 893 981 78 128 125 130 163
2025/20264.285 349 205 343 374 451 302 1.250 249 263 499 0 0
Totale 100.748